Matthew Yeowart
Lawyers
Filters
GSK strategic alliance with Vesalius Therapeutics
We advised GSK on the transaction
ATSG $3.1 billion acquisition by Stonepeak
We are advising Air Transport Services Group on its going-private transaction
Nippon Paint Holdings $2.3 billion AOC acquisition
We are advising Nippon Paint on the acquisition
Crane NXT £300 million acquisition of De La Rue’s authentication division
We are advising Crane NXT on the acquisition
Arcadium Lithium $6.7 billion acquisition by Rio Tinto
We are advising Arcadium Lithium on the transaction
Emerson $3.5 billion sale of remaining interests in Copeland to Blackstone
We are advising Emerson on the sale
$100 million investment by consortium in Airbus subsidiary AALTO
We are advising Airbus on the transaction
Nuvei $6.3 billion going-private acquisition
We are advising Nuvei on the transaction
MSCI acquisition of Foxberry
We are advising MSCI on the acquisition
Bridgepoint sale of a minority interest in Humanetics
We are advising Bridgepoint and Humanetics on the transaction